Max Healthcare Institute Limited (NSE:MAXHEALTH) disclosed on 13 August 2026 that its Nomination and Remuneration Committee approved the allotment of 3,048 fully paid-up equity shares of face value Rs 10 each to eligible employees under the Max Healthcare Institute Limited Employee Stock Option Scheme 2022, at an exercise price of Rs 350 per share.
Key Highlights
- The NRC meeting, held on 13 August 2026 between 7:50 am and 8:20 am IST, approved the allotment of 3,048 equity shares under the Employee Stock Option Scheme 2022.
- The exercise price per share was Rs 350, carrying a premium of Rs 340 over the face value of Rs 10 per equity share.
- Post-allotment, the total paid-up equity share capital stands at Rs 973,27,64,860, comprising 97,32,76,486 equity shares.
- The allotted shares are identical in all respects to existing equity shares and have been issued in dematerialised form with ISIN INE027H01010, with no lock-in applicable.
About the Company
Max Healthcare Institute Limited (NSE:MAXHEALTH), headquartered at Vile Parle (West), Mumbai, is one of India's largest private hospital networks. The company operates multi-specialty hospitals and cancer centres primarily across Delhi-NCR, Punjab, Haryana, Uttarakhand, and Maharashtra, offering tertiary and quaternary healthcare services. Its shares are listed on both BSE (scrip code 543220) and NSE.
Announcement in Detail
The NRC of Max Healthcare Institute Limited convened on 13 August 2026 and approved the allotment of 3,048 equity shares to eligible employees who had exercised vested stock options under the Max Healthcare Institute Limited Employee Stock Option Scheme 2022. The scheme was originally filed with the exchanges on 29 September 2022, bearing BSE reference DCS/IPO/MJ/ESOP-IP/2511/2022-23 and NSE reference NSE/LIST/32765.
Each share carries a face value of Rs 10 and was allotted at an exercise price of Rs 350, implying a premium of Rs 340 per share. The distinctive numbers assigned to the newly allotted shares run from 97,32,73,439 to 97,32,76,486 (both inclusive). The company confirmed that the allotment is not material under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Impact on Investors
The filing shows that this allotment increases the total equity share count by 3,048 shares, taking the outstanding shares from 97,32,73,438 to 97,32,76,486. The incremental increase relative to total outstanding shares is extremely small, and the disclosed terms indicate no dilution of meaningful scale for existing shareholders. Investors will note that no lock-in period applies to the allotted shares, meaning the newly allotted shares are freely transferable from the date of allotment.
Shareholders will observe that the paid-up equity capital has risen by Rs 30,480, reflecting only the face value component of the 3,048 shares. The company confirmed the allotment does not cross the materiality threshold under Regulation 30, so no further regulatory disclosures are mandated solely on this basis.
Sector / Market Context
Employee stock option schemes are a widely adopted retention mechanism in India's private hospital sector, where competition for qualified clinical and managerial talent is significant. SEBI's Share Based Employee Benefits and Sweat Equity Regulations, 2021, govern the disclosure and allotment process for such schemes. Periodic ESOP allotments of this nature are routine for listed healthcare companies and reflect ongoing vesting cycles rather than discrete capital-raising events. The broader private healthcare sector has seen rising institutional participation, with several large hospital networks expanding capacity across Tier-1 and Tier-2 cities over recent years according to publicly reported industry data.